All SEC Filings :: Zivo Bioscience, Inc. (ZIVO)

Filing Type:

Year:

Date	Form	Description	Pages
12/09/03	PREM14C	Preliminary information statements relating to merger or acquisition	4
12/09/03	8-K	Current report filing Documents EX-2 EX-16	26
11/25/03	SC 13D	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Documents EX-99	20
11/24/03	3	Initial statement of beneficial ownership of securities	2
11/21/03	4	Statement of changes in beneficial ownership of securities	1
11/21/03	4	Statement of changes in beneficial ownership of securities	1
10/28/03	10QSB	Optional form for quarterly and transition reports of small business issuers Documents EX-99.1	10
08/08/03	10QSB	Optional form for quarterly and transition reports of small business issuers Documents EX-99	10
05/06/03	10QSB	Optional form for quarterly and transition reports of small business issuers Documents EX-99.1	10
03/28/03	10KSB	Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405] Documents EX-99	22

Our Research Partners

DairyExperts

We conducted in vivo pre-pilot and pilot studies in dairy cows with leading mastitis experts at a research firm based in Tulare County, California, showing positive results for combatting bovine mastitis, an inflammatory condition of the udder that impacts milk production.

Synthetic Genomics, Inc.

Commercial scaling and process improvements for algae cultivation were performed at SGI's Imperial Valley Facility, while the La Jolla facility mapped the genome of our proprietary algae strain in anticipation of a strain development program.

Harmon Consulting, Inc. (HCI)

We have worked with HCI on crucial technical aspects toward advancing our algae cultivation and processing technology. Their contributions span cultivation science, downstream processing, quality systems, and GRAS certification of the product. Their support in the development and training of the production staff will help to ensure ongoing project success.
www.harmonalgae.com

Contract Research Organizations

Our company works with leading CROs such as Charles River, a global contract research organization, and others to test, validate and analyze our products as we move toward market readiness.

Licensing Opportunities

Potential partners and licensees require proof that our nutritional and active components deliver on claims, therefore, we have engaged in a variety of validation, safety, interactions, and stability tests to prove such claims, and meet compliance regulations set forth by the FDA, USDA, EPA, and FTC.

We follow specific protocols and processes for all licensing packages, including our models for efficacy and compliance. Our intention is to expand our potential licensing opportunities based on new research and development data in the near future.

All SEC Filings